Gnosis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.57 Cr
as on 16-11-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.33 Cr
as on 16-11-2024
- Satisfied Charges ₹ 15.48 Cr
as on 16-11-2024
- Revenue 23.07%
(FY 2023)
- Profit 379.42%
(FY 2023)
- Ebitda 50.96%
(FY 2023)
- Net Worth 9.17%
(FY 2023)
- Total Assets 1.75%
(FY 2023)
About Gnosis Pharmaceuticals
The Corporate was formerly known as Kaizen Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.57 Cr.
The company currently has active open charges totaling ₹30.33 Cr. The company has closed loans amounting to ₹15.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surendra Yadav, Mool Sonkar, Rajesh Khurana, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL2005PTC134162
- Company No.
134162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gnosis Pharmaceuticals Private Limited offer?
Gnosis Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Pharmaceutical Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Psoriasis Ointment, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Gnosis Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Yadav  | Additional Director | 04-Jul-2024 | Current |
| Mool Sonkar | Director | 11-Jan-2021 | Current |
| Rajesh Khurana | Director | 26-Nov-2011 | Current |
| Ramesh Khurana | Director | 26-Nov-2011 | Current |
Financial Performance of Gnosis Pharmaceuticals.
Gnosis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.07% increase. The company also saw a substantial improvement in profitability, with a 379.42% increase in profit. The company's net worth moved up by a moderate rise of 9.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gnosis Pharmaceuticals?
In 2023, Gnosis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Mar 2024 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 10 Dec 2021 | ₹2.50 M | Open |
Hdfc Bank Limited Creation Date: 10 Dec 2021 | ₹2.50 M | Open |
How Many Employees Work at Gnosis Pharmaceuticals?
Gnosis Pharmaceuticals has a workforce of 260 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gnosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnosis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
